Literature DB >> 8200419

Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain.

D J Anderson1, S P Arneric.   

Abstract

Three radiolabeled nicotinic receptor agonists were examined for their binding characteristics and for inhibition by cholinergic compounds in order to distinguish possible differential affinities for subtypes of neuronal nicotinic acetylcholine receptors. KD and Bmax values for [3H]cytisine, [3H]methylcarbamylcholine and [3H]nicotine were determined from Scatchard analysis using an enriched whole-brain membrane fraction from male Sprague-Dawley rats. Respective KD values were 0.15, 1.07 and 0.89 nM while Bmax values were 99, 64 and 115 fmol/mg protein respectively. All three ligands fit a one-site model of receptor-ligand interaction. Concentration-inhibition curves were used to determine Ki values for 16 cholinergic compounds. The rank order of potencies for displacement of the three ligands was: (-)-cytisine > (-)-nicotine > (-)-lobeline = methylcarbamylcholine > 1,1-dimethyl-4-phenylpiperazinium, (+)-nicotine, dihydro-beta-erythroidine, (+/-)-nornicotine > carbachol > arecoline >> oxotremorine, tetrahydroaminoacridine, AF102B >> (-)-cotinine > RS86 = heptylphysostigmine. Correlations of the affinities of these compounds determined with the three ligands were very near to unity. In contrast, there was a negative correlation of affinities for [3H]cytisine compared to affinities for the muscarinic receptor agonist, [3H]oxotremorine-M, and the muscarinic receptor antagonist, [3H]quinuclidinyl benzoate. Using membranes from whole rat brain yields data suggesting that all three nicotinic ligands bind to the same nicotinic acetylcholine receptor subtype, and are unable to distinguish subtypes of neuronal nicotinic acetylcholine receptor at the level examined.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200419     DOI: 10.1016/0014-2999(94)90200-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  29 in total

1.  Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis.

Authors:  Andrea Nören-Müller; Ivan Reis-Corrêa; Heino Prinz; Claudia Rosenbaum; Krishna Saxena; Harald J Schwalbe; Dietmar Vestweber; Guiseppe Cagna; Stefan Schunk; Oliver Schwarz; Hajo Schiewe; Herbert Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-29       Impact factor: 11.205

2.  Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.

Authors:  Sheela K Chellappan; Yingxian Xiao; Werner Tueckmantel; Kenneth J Kellar; Alan P Kozikowski
Journal:  J Med Chem       Date:  2006-05-04       Impact factor: 7.446

3.  Nicotine modulates alcohol-seeking and relapse by alcohol-preferring (P) rats in a time-dependent manner.

Authors:  Sheketha R Hauser; Bruk Getachew; Scott M Oster; Ronnie Dhaher; Zheng-Ming Ding; Richard L Bell; William J McBride; Zachary A Rodd
Journal:  Alcohol Clin Exp Res       Date:  2011-06-20       Impact factor: 3.455

4.  Dopaminergic and cholinergic involvement in the discriminative stimulus effects of nicotine and cocaine in rats.

Authors:  Rajeev I Desai; David J Barber; Philip Terry
Journal:  Psychopharmacology (Berl)       Date:  2003-04-09       Impact factor: 4.530

5.  Isolation and microsequencing of a novel cotinine receptor.

Authors:  O Riah; J C Dousset; E Bofill-Cardona; P Courrière
Journal:  Cell Mol Neurobiol       Date:  2000-12       Impact factor: 5.046

6.  Radioiodination of nicotine with specific activity high enough for mapping nicotinic acetylcholine receptors.

Authors:  I Kämpfer; D Sorger; R Schliebs; W Kärger; K Günther; K Schulze; W H Knapp
Journal:  Eur J Nucl Med       Date:  1996-02

7.  Rhodium(I)-catalyzed allenic carbocyclization reaction affording delta- and epsilon-lactams.

Authors:  Kay M Brummond; Thomas O Painter; Donald A Probst; Branko Mitasev
Journal:  Org Lett       Date:  2007-01-18       Impact factor: 6.005

Review 8.  Regulation of feeding-associated peptides and receptors by nicotine.

Authors:  M D Li; S L Parker; J K Kane
Journal:  Mol Neurobiol       Date:  2000 Aug-Dec       Impact factor: 5.590

9.  Evaluation of nicotine and cotinine analogs as potential neuroprotective agents for Alzheimer's disease.

Authors:  Jie Gao; Bao-Ling Adam; Alvin V Terry
Journal:  Bioorg Med Chem Lett       Date:  2014-02-14       Impact factor: 2.823

Review 10.  Nicotinic agonists, antagonists, and modulators from natural sources.

Authors:  John W Daly
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.